Patent · US Active

Swine influenza hemagglutinin variants

US9017694B2 · kind B2 · utility

3Cited by
7References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2012
Grant dateApr 28, 2015
Priority date—
Expiry dateApr 6, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16151
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The technology relates in part to modified influenza viruses useful for vaccine development. Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.